October 25, 2016 3:15 PM ET


Company Overview of Intrexon Corporation

Executive Profile

James S. Turley

Independent Director and Chairman of Compensation Committee, Intrexon Corporation
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 9 different industries.

See Board Relationships


Mr. James S. Turley, also known as Jim, serves as Chairman of the National Corporate Theatre Fund. Mr. Turley has been an Independent Director of Northrop Grumman Corporation since February 19, 2015. He has been a Director of Citigroup Inc. since July 2013 and has been an Independent Director of Emerson Electric Co. since July 10, 2013. He has been an Independent Director of Intrexon Corporation since April 16, 2014. Mr. Turley serves on President Obama's Export Council. ...

Corporate Headquarters

20374 Seneca Meadows Parkway
Germantown, Maryland 20876

United States

Phone: 301-556-9900
Fax: --

Board Members Memberships

Independent Director, Chairman of Audit Committee, Member of Executive Committee and Member of Corporate Governance & Nominating Committee
Director, Chairman of Audit Committee, Member of Executive Committee and Member of Risk Management Committee
Independent Director and Chairman of Compensation Committee
Independent Director, Member of Audit Committee and Member of Governance Committee


Bachelor's Degree
Rice University
Master's Degree
Rice University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$41,403
Exercisable Options Value$289,822
Unexercisable Options$31,053
Unexercisable Options Value$347,794
Total Value of Options$637,616
Total Number of Options$72,456

Total Compensation

Total Annual Cash Compensation$59,967
Total Calculated Compensation$459,563

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Nick Leschly Chief Executive Officer, President and Director
bluebird bio, Inc.
André Choulika Ph.D.Co-Founder, Chairman and Chief Executive Officer
Cellectis S.A.
James Julian Noble M.A., F.C.A.Chief Executive Officer and Director
Adaptimmune Therapeutics plc
Arie S. Belldegrun M.D., FACSFounder, Executive Chairman, Chief Executive Officer, President and Member of International Strategy Committee
Kite Pharma, Inc.
Hans E. Bishop Co-Founder, Chief Executive Officer, President and Director
Juno Therapeutics Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Intrexon Corporation, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.